These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 16940305)

  • 1. BSR/BHPR guideline for disease-modifying anti-rheumatic drug (DMARD) therapy in consultation with the British Association of Dermatologists.
    Chakravarty K; McDonald H; Pullar T; Taggart A; Chalmers R; Oliver S; Mooney J; Somerville M; Bosworth A; Kennedy T; ;
    Rheumatology (Oxford); 2008 Jun; 47(6):924-5. PubMed ID: 16940305
    [No Abstract]   [Full Text] [Related]  

  • 2. Comment on: BSR/BHPR guideline for disease-modifying anti-rheumatic drug (DMARD) therapy in consultation with the British Association of Dermatologists.
    Bhalla AK; Samaranayaka M
    Rheumatology (Oxford); 2008 Oct; 47(10):1591; author reply 1591. PubMed ID: 18676499
    [No Abstract]   [Full Text] [Related]  

  • 3. An evidence-based assessment of the clinical significance of drug-drug interactions between disease-modifying antirheumatic drugs and non-antirheumatic drugs according to rheumatologists and pharmacists.
    van Roon EN; van den Bemt PM; Jansen TL; Houtman NM; van de Laar MA; Brouwers JR
    Clin Ther; 2009 Aug; 31(8):1737-46. PubMed ID: 19808132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BSR and BHPR rheumatoid arthritis guidelines on safety of anti-TNF therapies.
    Ding T; Ledingham J; Luqmani R; Westlake S; Hyrich K; Lunt M; Kiely P; Bukhari M; Abernethy R; Bosworth A; Ostor A; Gadsby K; McKenna F; Finney D; Dixey J; Deighton C; ;
    Rheumatology (Oxford); 2010 Nov; 49(11):2217-9. PubMed ID: 20837498
    [No Abstract]   [Full Text] [Related]  

  • 5. Rheumatoid arthritis, alcohol, leflunomide and methotrexate. Can changes to the BSR guidelines for leflunomide and methotrexate on alcohol consumption be justified?
    Rajakulendran S; Gadsby K; Deighton C
    Musculoskeletal Care; 2008 Dec; 6(4):233-45. PubMed ID: 18702106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of early rheumatoid arthritis.
    Suresh E
    J Assoc Physicians India; 2007 May; 55():355-62. PubMed ID: 17844697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rheumatology. Part 2: The role of medication.
    Byrne J
    Prof Nurse; 1999 Feb; 14(5):353-8. PubMed ID: 10205553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response-driven combination therapy with conventional disease-modifying antirheumatic drugs can achieve high response rates in early rheumatoid arthritis with minimal glucocorticoid and nonsteroidal anti-inflammatory drug use.
    Proudman SM; Keen HI; Stamp LK; Lee AT; Goldblatt F; Ayres OC; Rischmueller M; James MJ; Hill CL; Caughey GE; Cleland LG
    Semin Arthritis Rheum; 2007 Oct; 37(2):99-111. PubMed ID: 17391739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outpatient follow-up for patients with rheumatoid arthritis in relation to New Zealand Rheumatology Association guidelines at Dunedin Hospital.
    Chan G; Goh F; Hodgson T; Hsu E; Johnstone D; Ly J; Platt T; Rodrigues E; Tsai W; Hider P; Gray A; Highton J
    N Z Med J; 2008 May; 121(1274):34-41. PubMed ID: 18535644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of explicit process of care measurement to rheumatoid arthritis: Moving from evidence to practice.
    Kahn KL; MacLean CH; Liu H; Rubenstein LZ; Wong AL; Harker JO; Chen WP; Fitzpatrick DM; Bulpitt KJ; Traina SB; Mittman BS; Hahn BH; Paulus HE
    Arthritis Rheum; 2006 Dec; 55(6):884-91. PubMed ID: 17139665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-dose prednisolone in rheumatoid arthritis: adverse effects of various disease modifying antirheumatic drugs.
    Malysheva OA; Wahle M; Wagner U; Pierer M; Arnold S; Häntzschel H; Baerwald CG
    J Rheumatol; 2008 Jun; 35(6):979-85. PubMed ID: 18412314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are biologics more effective than classical disease-modifying antirheumatic drugs?
    Nurmohamed MT; Dijkmans BA
    Arthritis Res Ther; 2008; 10(5):118. PubMed ID: 18828888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Choice of second-line disease-modifying antirheumatic drugs after failure of methotrexate therapy for rheumatoid arthritis: a decision tree for clinical practice based on rheumatologists' preferences.
    Fautrel B; Guillemin F; Meyer O; de Bandt M; Berthelot JM; Flipo RM; Lioté F; Maillefert JF; Wendling D; Saraux A; Combe B; Le Loët X; ; ;
    Arthritis Rheum; 2009 Apr; 61(4):425-34. PubMed ID: 19333993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Is the guideline, "Management of early rheumatoid arthritis," being followed in a rheumatism center?].
    Hartmann M; Gundermann C; Richter A; Eidner T; Hein G
    Dtsch Med Wochenschr; 2008 Aug; 133(34-35):1721-4. PubMed ID: 18696403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. I take a disease-modifying antirheumatic drug (DMARD) for my rheumatoid arthritis pain. But is there a non-drug treatment or therapy I can use to deal with intermittent pain or flareups?
    Duke Med Health News; 2011 May; 17(5):8. PubMed ID: 21766534
    [No Abstract]   [Full Text] [Related]  

  • 16. BSR and BHPR guideline for the prescription and monitoring of non-biologic disease-modifying anti-rheumatic drugs.
    Ledingham J; Gullick N; Irving K; Gorodkin R; Aris M; Burke J; Gordon P; Christidis D; Galloway S; Hayes E; Jeffries A; Mercer S; Mooney J; van Leuven S; Galloway J;
    Rheumatology (Oxford); 2017 Jun; 56(6):865-868. PubMed ID: 28339817
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug management of early rheumatoid arthritis - 2008.
    Sokka T; Mäkinen H
    Best Pract Res Clin Rheumatol; 2009 Feb; 23(1):93-102. PubMed ID: 19233049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rational disease-modifying anti-rheumatic drug (DMARD) therapy: is it possible?
    Furst DE
    Br J Rheumatol; 1996 Aug; 35(8):707-8. PubMed ID: 8761179
    [No Abstract]   [Full Text] [Related]  

  • 19. Patient decision-making related to antirheumatic drugs in rheumatoid arthritis: the importance of patient trust of physician.
    Martin RW; Head AJ; René J; Swartz TJ; Fiechtner JJ; McIntosh BA; Holmes-Rovner M
    J Rheumatol; 2008 Apr; 35(4):618-24. PubMed ID: 18278840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Disease-modifying anti-rheumatic drugs for treatment of ankylosing spondylitis].
    Madsen OR; Egsmose C
    Ugeskr Laeger; 2009 Aug; 171(33):2268-72. PubMed ID: 19732504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.